Baudax Bio, Inc.
BXRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.5% | 119.1% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -452.3% | -126.4% | -251.3% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,803.6% | -4,468.5% | -15,169.6% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,633.2% | -1,830.5% | -15,436.1% | – |
| EPS Diluted | -177.3 | -361.16 | -5,715.36 | -2,695.87 |
| % Growth | 50.9% | 93.7% | -112% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |